Osaic Holdings’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$406K Buy
12,412
+2,100
+20% +$67.4K ﹤0.01% 3836
2026
Q1
$336K Buy
10,312
+52
+0.5% +$1.71K ﹤0.01% 3722
2025
Q4
$326K Buy
10,260
+55
+0.5% +$1.65K ﹤0.01% 3729
2025
Q3
$213K Buy
10,205
+2,717
+36% +$46.6K ﹤0.01% 4156
2025
Q2
$85K Buy
7,488
+5,427
+263% +$51.5K ﹤0.01% 4640
2025
Q1
$13.7K Buy
2,061
+2,000
+3,279% +$18.6K ﹤0.01% 5611
2024
Q4
$672 Sell
61
-15
-20% -$184 ﹤0.01% 6940
2024
Q3
$933 Sell
76
-8
-10% -$113 ﹤0.01% 6860
2024
Q2
$1.14K Buy
84
+23
+38% +$311 ﹤0.01% 6778
2024
Q1
$823 Buy
+61
New +$370 ﹤0.01% 6723
2023
Q3
Sell
-100
Closed -$1.06K 7530
2023
Q2
$1.06K Sell
100
-217
-68% -$2.31K ﹤0.01% 6859
2023
Q1
$2.64K Buy
317
+125
+65% +$1.13K ﹤0.01% 6601
2022
Q4
$1K Sell
192
-128
-40% -$1.33K ﹤0.01% 6957
2022
Q3
$4K Hold
320
﹤0.01% 6521
2022
Q2
$4K Hold
320
﹤0.01% 6631
2022
Q1
$6K Buy
320
+10
+3% +$200 ﹤0.01% 6415
2021
Q4
$7K Buy
310
+10
+3% +$239 ﹤0.01% 6490
2021
Q3
$8K Hold
300
﹤0.01% 6339
2021
Q2
$10K Hold
300
﹤0.01% 6078
2021
Q1
$12K Hold
300
﹤0.01% 5793
2020
Q4
$19K Hold
300
﹤0.01% 5197
2020
Q3
$10K Buy
+300
New +$8.57K ﹤0.01% 5275

Other funds holding STOK

Osaic Holdings's STOK Position: Q2 2026 in Review

Osaic Holdings increased its Stoke Therapeutics (STOK) stake by 20% in Q2 2026, buying an estimated $67.4K and bringing the position to 12,412 shares worth $406K. The position accounts for ﹤0.01% of the portfolio, ranked #3836.

Osaic Holdings first reported a position in STOK in Q3 2020 and has held it in 22 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Osaic Holdings held 12,412 shares of Stoke Therapeutics worth $406K as of Q2 2026.
  • Osaic Holdings bought 2,100 Stoke Therapeutics shares in Q2 2026, an estimated $67.4K.
  • Stoke Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3836 holding.
  • Osaic Holdings first reported a position in Stoke Therapeutics in Q3 2020 and has held it in 22 quarters since.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.